TEV-45478
- Generic Name
- TEV-45478
A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 Diabetes
Phase 2
Withdrawn
- Conditions
- Nonalcoholic SteatohepatitisType 2 Diabetes Mellitus
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-05-11
- Last Posted Date
- 2021-11-09
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Registration Number
- NCT02769091
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath